CogState Hisse

CogState Kural 40

Delisted·15 Haz 2026

CogState (CGS.AX) öğesinin 40 Kuralı değeri 14 Ağu 2026 itibarıyla 46,88 % dir. Önceki yılda, 40 Kuralı 23,65 % idi — 98,22% (daha yüksek) bir değişiklik.

Kural 40

46,88 %

YoY

98,22%

Son güncelleme:

CogState öğesinin 40 Kuralı değeri 2026 46,88 % dir. CogState öğesinin 40 Kuralı değeri 2025 23,65 % idi. %98,22 daha yüksek önceki yıla kıyasla azalmaktadır.
Access this data via the Eulerpool API

CogState Hisse senedi analizi

CogState ne yapar? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState, Eulerpool'daki en popüler şirketlerden biridir.

CogState hisse senedi hakkında sık sorulan sorular

CogState şirketinin 40 Kuralı değeri 2026 yılında 46,88 %.

Eulerpool'da 40 Kuralı öğesinin CogState değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

40 Kuralı, şirketin gelir büyüme oranı artı kar marjının 40%'i aşması gerektiğini belirtir. SaaS ve yüksek büyüme gösteren şirketleri değerlendirmek için yaygın olarak kullanılır.

Access this data via the Eulerpool API

Kalite — CogState

Tüm Kilit Metrikler — CogState